Which of the following are TRUE about disease modulating agents? (Select all that apply.)
Disease modulating agents treat only RRMS.
Disease modulating medications do not cause health risks.
Disease modulating medications reduce the frequency and severity of exacerbations.
Disease modulating agents treat all forms of MS.
There are 5 drugs approved by the U. S.FDA to modify the progression of the disease.
Disease modulating medications can carry significant health risks.

Anurse is instructing a client who has a new prescription for a daily dose of lovastatin extended release. which of the following information should the nurse include in the teaching? a. report to the clinic for quarterly monitoring of kidney function while taking this medication. b. mix with applesauce after crushing if the medication is difficult to swallow. c. avoid consuming dairy products while taking this medication. d. take the medication with the evening meal.

Anurse is caring for a client who is receiving a continuous iv infusion of magnesium sulfate for preterm labor. the nurse should discontinue the infusion and prepare to administer calcium gluconate if the client demonstrates which of the following findings? (select all that apply) a. urine output 80 ml in 4 hr b. absence of deep-tendon reflexes c. report of chills d. decreased level of consciousness e. systolic blood pressure 130 mm hg

Cj is a 53 year old african american female presenting to pharmacy for first-time certification and cmr so that she may start getting her medications at no cost. cj states that her main concern about her health is her diabetes. pmh: t2dm, htn, hyperlipidemia sh: denies tobacco and illicit drug use, occasional alcohol use (1-2 drinks/month) fh: unknown allergies: penicillin (unknown reaction; had reaction when young). medications: lisinopril 5 mg daily aspirin 81 mg daily simvastatin 20 mg daily wt 231 lbs (105 kg), ht 5’6”, bmi 37.3 (obese), ibw 59.3 kg, bp 145/80, hr 98, random blood glucose 395, a1c 11.2%, estimated 10-year ascvd risk 9.5% drug-related problems: 1. uncontrolled t2dm 2. uncontrolled htn 3. suboptimal statin intensity 1) identify two pieces of objective data included in this case: 2) what kind of monitoring needs performed for the new prescription for this patient? 3) based on your case how would you counsel the patient on the new prescription medication? provide examples of specific aspects you would include in your patient education. 4) review your patient case. identify any medications that do not have a corresponding disease state. 5) review your patient case. identify any disease states are not treated by current medications. 6) what otc (over the counter) product would you recommend for this patient (based on the patient request for an otc product? include dose, frequency of administration, route of administration, and critical counseling points.